# LAMP5

## Overview
LAMP5, or lysosomal-associated membrane protein family member 5, is a gene that encodes a single-transmembrane protein predominantly expressed in the brain and certain immune cells. The LAMP5 protein is a member of the lysosomal-associated membrane protein family, which is involved in various cellular processes, including autophagy, phagocytosis, and immune signaling. Unlike other LAMP family proteins, LAMP5 is not typically localized to late endosomes or lysosomes but is instead found in specific neuronal subtypes and plasmacytoid dendritic cells, where it plays a role in immune response modulation and neuronal function (Koebis2019LAMP5; Chen2023LAMP5). The protein's unique expression pattern and functional roles in both the nervous and immune systems underscore its significance in maintaining cellular homeostasis and its potential implications in disease contexts such as leukemia, multiple myeloma, and Alzheimer's disease (Deng2022Loss; Wang2019Activation).

## Structure
LAMP5 is a single-transmembrane protein composed of 280 amino acids, with a molecular weight of 31.7 kDa. It features a luminal domain containing four well-conserved cysteines, a transmembrane domain, and a cytoplasmic tail. The cytoplasmic tail shares sequence and structural homology with other lysosomal-associated membrane proteins, LAMP1 and LAMP2 (Umeda2022Lysosomalassociated). 

LAMP5 is distinct from other LAMP proteins like LAMP1 and LAMP2, as it is almost exclusively expressed in the brain and is not targeted to late endosomal/lysosomal compartments (Koebis2019LAMP5). The protein is associated with lysosomal membranes and is involved in lysosomal functions, including roles in autophagosomal and phagosomal processes (Umeda2022Lysosomalassociated). 

Post-translational modifications such as glycosylation are common in LAMP family proteins, which can affect their stability and function, although specific modifications for LAMP5 are not detailed in the provided context. The molecular structure of LAMP5, including specific secondary, tertiary, or quaternary structures, is not explicitly detailed in the available sources. The protein's role in various cellular processes, such as autophagy and apoptosis, is highlighted through its interactions with other proteins like ANXA7 (Li2023Targeting).

## Function
LAMP5, also known as BAD-LAMP, is a member of the lysosome-associated membrane protein family, primarily expressed in the brain and certain blood cells. In healthy human cells, LAMP5 is involved in various cellular processes, including phagocytosis, autophagy, lipid transport, and senescence, which are crucial for maintaining cellular homeostasis and function (Chen2023LAMP5). Unlike other LAMP proteins, LAMP5 does not localize to late endosomes or lysosomes but is found in specific tissues, particularly in the brain, where it is expressed in subtypes of cortical projecting neurons (Alessandrini2017LAMPs:).

In the immune system, LAMP5 is expressed in type I interferon-producing plasmacytoid dendritic cells (pDCs), where it plays a role in the transport of TLR9 from early endosomal to lysosomal signaling vesicles, mediating type 1 interferon and proinflammatory signaling (Qian2022Differentially). This suggests its involvement in innate immune signaling pathways. LAMP5 also leads to the activation of nuclear transcription factor-kappa B (NF-κB) and the production of tumor necrosis factor (TNF) upon DNA detection, highlighting its role in immune response modulation (Chen2023LAMP5). These functions underscore LAMP5's importance in both neuronal and immune cell biology.

## Clinical Significance
Alterations in the expression of the LAMP5 gene have been implicated in several diseases, particularly in the context of cancer and neurological disorders. In mixed-lineage leukemia (MLL), LAMP5 is highly expressed and associated with poor outcomes. It acts as a suppressor of autophagy, protecting MLL fusion proteins from degradation, which contributes to leukemia progression. Knockdown of LAMP5 in MLL leukemia cell lines reduces MLL fusion protein levels, decreases cell proliferation, and increases apoptosis, suggesting its potential as a therapeutic target (Wang2019Activation).

In multiple myeloma (MM), LAMP5 is upregulated, with higher expression levels correlating with poor prognosis. Its expression is higher in newly diagnosed MM patients compared to healthy donors and decreases after treatment. LAMP5 knockdown in MM cell lines leads to increased apoptosis, indicating its role in inhibiting apoptosis and promoting MM progression (Chen2023LAMP5).

In Alzheimer's disease (AD), LAMP5 is identified as a regulator of neuronal hyperexcitation. Loss of LAMP5 in AD brains contributes to neuronal network dysfunction, exacerbating functional deficits and hypersynchronicity in mouse models. This suggests that LAMP5 plays a critical role in maintaining neuronal network stability, and its loss may contribute to AD pathogenesis (Deng2022Loss).

## Interactions
LAMP5, a member of the lysosomal-associated membrane protein family, participates in several protein interactions that influence cellular processes. In the context of MLL leukemia, LAMP5 interacts with the autophagy-related protein ATG5. This interaction has been demonstrated through co-immunoprecipitation and immunofluorescence experiments, suggesting that LAMP5 may regulate autophagy processes in leukemia cells by modulating ATG5 activity (Wang2019Activation).

LAMP5 also interacts with UNC-93B1, a protein involved in Toll-like receptor (TLR) trafficking, within the human immune system. This interaction affects the intracellular localization of both proteins, indicating a potential role for LAMP5 as a trafficking chaperone (Tiveron2016LAMP5).

In the context of MLL-rearranged leukemias, LAMP5 is involved in the transportation of TLR9, affecting signaling pathways that include NF-kB and type I interferons. This suggests that LAMP5 plays a role in inflammatory signaling regulation (GraciaMaldonado2021LAMP5).

These interactions highlight LAMP5's involvement in critical cellular pathways, including autophagy and immune signaling, which may contribute to its roles in disease contexts such as leukemia and immune regulation.


## References


1. (Qian2022Differentially) Differentially expressed gene profile and relevant pathways of the inhibition of LAMP5 on MLL-rearranged leukemias. This article has 0 citations.

[2. (Chen2023LAMP5) Yan Chen and Tao Ma. Lamp5 may promote mm progression by activating p38. Pathology and Oncology Research, March 2023. URL: http://dx.doi.org/10.3389/pore.2023.1611083, doi:10.3389/pore.2023.1611083. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/pore.2023.1611083)

[3. (Tiveron2016LAMP5) Marie-Catherine Tiveron, Corinne Beurrier, Claire Céni, Naly Andriambao, Alexis Combes, Muriel Koehl, Nicolas Maurice, Evelina Gatti, Dhoher Nora Abrous, Lydia Kerkerian-Le Goff, Philippe Pierre, and Harold Cremer. Lamp5 fine-tunes gabaergic synaptic transmission in defined circuits of the mouse brain. PLOS ONE, 11(6):e0157052, June 2016. URL: http://dx.doi.org/10.1371/journal.pone.0157052, doi:10.1371/journal.pone.0157052. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0157052)

[4. (Koebis2019LAMP5) Michinori Koebis, Shinji Urata, Yo Shinoda, Shigeo Okabe, Tatsuya Yamasoba, Kazuki Nakao, Atsu Aiba, and Teiichi Furuichi. Lamp5 in presynaptic inhibitory terminals in the hindbrain and spinal cord: a role in startle response and auditory processing. Molecular Brain, March 2019. URL: http://dx.doi.org/10.1186/s13041-019-0437-4, doi:10.1186/s13041-019-0437-4. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13041-019-0437-4)

[5. (Wang2019Activation) Wen-Tao Wang, Cai Han, Yu-Meng Sun, Zhen-Hua Chen, Ke Fang, Wei Huang, Lin-Yu Sun, Zhan-Cheng Zeng, Xue-Qun Luo, and Yue-Qin Chen. Activation of the lysosome-associated membrane protein lamp5 by dot1l serves as a bodyguard for mll fusion oncoproteins to evade degradation in leukemia. Clinical Cancer Research, 25(9):2795–2808, May 2019. URL: http://dx.doi.org/10.1158/1078-0432.ccr-18-1474, doi:10.1158/1078-0432.ccr-18-1474. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-18-1474)

[6. (GraciaMaldonado2021LAMP5) Gabriel Gracia-Maldonado, Jason Clark, Matthew Burwinkel, Brenay Greenslade, Mark Wunderlich, Nathan Salomonis, Dario Leone, Evelina Gatti, Philippe Pierre, Ashish R. Kumar, and Lynn H. Lee. Lamp-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia. Haematologica, 107(4):803–815, April 2021. URL: http://dx.doi.org/10.3324/haematol.2020.257451, doi:10.3324/haematol.2020.257451. This article has 10 citations.](https://doi.org/10.3324/haematol.2020.257451)

[7. (Umeda2022Lysosomalassociated) Shinichi Umeda, Mitsuro Kanda, Dai Shimizu, Shunsuke Nakamura, Koichi Sawaki, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama, and Yasuhiro Kodera. Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells. Gastric Cancer, 25(3):558–572, February 2022. URL: http://dx.doi.org/10.1007/S10120-022-01284-Y, doi:10.1007/s10120-022-01284-y. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/S10120-022-01284-Y)

[8. (Li2023Targeting) Na Li, Lu Chen, Xiaoqing Zhao, Chi Gu, Yong Chang, and Shiqing Feng. Targeting anxa7/lamp5-mtor axis attenuates spinal cord injury by inhibiting neuronal apoptosis via enhancing autophagy in mice. Cell Death Discovery, August 2023. URL: http://dx.doi.org/10.1038/s41420-023-01612-w, doi:10.1038/s41420-023-01612-w. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-023-01612-w)

[9. (Deng2022Loss) Yuanyuan Deng, Mian Bi, Fabien Delerue, Shelley L. Forrest, Gabriella Chan, Julia van der Hoven, Annika van Hummel, Astrid F. Feiten, Seojin Lee, Ivan Martinez-Valbuena, Tim Karl, Gabor G. Kovacs, Grant Morahan, Yazi D. Ke, and Lars M. Ittner. Loss of lamp5 interneurons drives neuronal network dysfunction in alzheimer’s disease. Acta Neuropathologica, 144(4):637–650, July 2022. URL: http://dx.doi.org/10.1007/s00401-022-02457-w, doi:10.1007/s00401-022-02457-w. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00401-022-02457-w)

[10. (Alessandrini2017LAMPs:) Federica Alessandrini, Laura Pezzè, and Yari Ciribilli. Lamps: shedding light on cancer biology. Seminars in Oncology, 44(4):239–253, August 2017. URL: http://dx.doi.org/10.1053/j.seminoncol.2017.10.013, doi:10.1053/j.seminoncol.2017.10.013. This article has 92 citations and is from a peer-reviewed journal.](https://doi.org/10.1053/j.seminoncol.2017.10.013)